Literature DB >> 8923071

Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients.

A Bach1, D Darby, B Böttiger, H Böhrer, J Motsch, E Martin.   

Abstract

OBJECTIVE: Antibiotic-coated intravascular catheters may be an effective means of decreasing bacterial colonization and subsequent catheter-related infection. The present study was designed to investigate the retention of the antibiotic teicoplanin on a hydromer-coated intravenous catheter and the effect of this antibiotic coating on catheter bacterial colonization.
DESIGN: A prospective, randomized pilot study.
SETTING: Operating rooms (ORs) and an intensive care unit (ICU) at a university hospital. PATIENTS: A consecutive group of 20 male patients undergoing major abdominal surgery.
INTERVENTIONS: Control (C; n = 10) or teicoplanin-coated (T; n = 10) single-lumen central venous catheters were inserted before surgery in the OR. Catheters were withdrawn at the discretion of the physicians in the ICU after various periods. MEASUREMENTS: The teicoplanin content of the catheter material was assessed using a bioassay with Bacillus subtilis after complete elution of the antibiotic from the catheter. Bacterial colonization was measured using a quantitative culture technique after the catheter lumen had been flushed and the catheter segments sonicated. MAIN
RESULTS: Nearly three-quarters of the initial teicoplanin coating (374 +/- 103 micrograms; mean +/- SD) were released during the first day of catheterization, and after 36 h of intravenous catheterization, no antibiotic was retained on the catheter. No significant difference could be found either in the incidence of bacterial colonization between test (n = 3) and control (n = 4) catheters or in the number of colony-forming units (CFU) on the catheter segments (T, 263 +/- 104 CFU/cm; C, 372 +/- 294 CFU/cm; mean +/- SEM).
CONCLUSION: The retention of teicoplanin antibiotic coating on hydromer catheters is only short term if catheters are inserted intravenously. This may limit clinical antibacterial efficacy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923071     DOI: 10.1007/bf01699229

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  10 in total

1.  In-vitro efficacy of a central venous catheter ('Hydrocath') loaded with teicoplanin to prevent bacterial colonization.

Authors:  B Jansen; S Jansen; G Peters; G Pulverer
Journal:  J Hosp Infect       Date:  1992-10       Impact factor: 3.926

2.  Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial.

Authors:  G D Kamal; M A Pfaller; L E Rempe; P J Jebson
Journal:  JAMA       Date:  1991-05-08       Impact factor: 56.272

3.  Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory.

Authors:  R J Sherertz; I I Raad; A Belani; L C Koo; K H Rand; D L Pickett; S A Straub; L L Fauerbach
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

Review 4.  Central venous catheter infections: concepts and controversies.

Authors:  C R Reed; C N Sessler; F L Glauser; B A Phelan
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

5.  Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.

Authors:  R J Sherertz; D M Forman; D D Solomon
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  Sepsis associated with central vein catheters in critically ill patients.

Authors:  P Collignon; N Soni; I Pearson; T Sorrell; P Woods
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse.

Authors:  G Romanò; M Berti; B P Goldstein; A Borghi
Journal:  Zentralbl Bakteriol       Date:  1993-08

8.  Nosocomial infections in intensive care wards: a multicenter prospective study.

Authors:  F D Daschner; P Frey; G Wolff; P C Baumann; P Suter
Journal:  Intensive Care Med       Date:  1982-01       Impact factor: 17.440

9.  Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.

Authors:  J I Greenfeld; L Sampath; S J Popilskis; S R Brunnert; S Stylianos; S Modak
Journal:  Crit Care Med       Date:  1995-05       Impact factor: 7.598

10.  Quantitative culture of intravenous catheters and other intravascular inserts.

Authors:  D J Cleri; M L Corrado; S J Seligman
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

  10 in total
  4 in total

Review 1.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16

Review 2.  Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections.

Authors:  Cesar Bustos; Aitziber Aguinaga; Francisco Carmona-Torre; Jose Luis Del Pozo
Journal:  Infect Drug Resist       Date:  2014-02-18       Impact factor: 4.003

Review 3.  Anti-biofilm Activity as a Health Issue.

Authors:  Sylvie Miquel; Rosyne Lagrafeuille; Bertrand Souweine; Christiane Forestier
Journal:  Front Microbiol       Date:  2016-04-26       Impact factor: 5.640

Review 4.  Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis.

Authors:  Hongliang Wang; Hongshuang Tong; Haitao Liu; Yao Wang; Ruitao Wang; Hong Gao; Pulin Yu; Yanji Lv; Shuangshuang Chen; Guiyue Wang; Miao Liu; Yuhang Li; Kaijiang Yu; Changsong Wang
Journal:  Ann Intensive Care       Date:  2018-06-15       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.